CNBC’s Meg Tirrell discusses the biotech sector’s worst day since January and what is driving the dip. The “Fast Money” traders weigh in.
- Grid Therapeutics Acquires Rights to Antibody for Cancer Immunotherapy7 hours ago
- Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present... read more8 hours ago
- Cantel Medical Completes Acquisition Of In Germany1 day ago
- The Best And Worst Biotech IPOs Of 20171 day ago
- 5 Startups to Watch Out For1 day ago
- Boston’s Paratek Heads to The Auction Block1 day ago
- Innately Innovative: IFM Therapeutics Acquired By BMS3 weeks ago
- First-generation stories: Headed to UCLA to continue cancer researchOur podcast catches up with new grad Hector Navarro, a first-generation college student who's off ... read more2 months ago
To access all our news feeds tap “Headlines“.